Predictive factors of conservative breast surgery after neoadjuvant chemotherapy for breast cancer

被引:1
作者
Pilloy, J. [1 ,2 ]
Fleurier, C. [1 ,2 ]
Chas, M. [1 ,2 ]
Bedouet, L. [1 ,2 ]
Jourdan, M. L. [3 ]
Arbion, F. [4 ]
Body, G. [1 ,2 ,4 ]
Ouldamer, L. [1 ,2 ,3 ]
机构
[1] CHRU Tours, Dept Gynecol, Hop Bretonneau, 2 Blvd Tonnelle, F-37044 Tours, France
[2] Fac Med Francois Rabelais, 10 Blvd Tonnelle, F-37044 Tours, France
[3] Unite Inserm 1069, 10 Blvd Tonnelle, F-37044 Tours, France
[4] CHRU Tours, Dept Pathol, Hop Bretonneau, 2 Blvd Tornnelle, F-37044 Tours, France
来源
GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE | 2017年 / 45卷 / 09期
关键词
Breast cancer; Neoadjuvant chemotherapy; Conservative surgery; Probability; PATHOLOGICAL COMPLETE RESPONSE; PROGNOSTIC-FACTORS; CORE BIOPSIES; RECURRENCE; MORTALITY; CARCINOMA; EXCISIONS; NOMOGRAM; THERAPY;
D O I
10.1016/j.gofs.2017.07.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. - The aim of our study was to evaluate the existence of predictive factors of conservative breast surgery after neoadjuvant chemotherapy (NAC) for breast cancer. Methods. - We included all women with invasive breast cancer who received NAC and underwent breast surgery between January 2007 and December 2013 in our institution. Univariable and multivariable analyses were performed to determine the association between clinical and histological factors and conservative breast surgery. Results. - During the study period, 229 women were included of whom 73 had breast.conservative surgery (32%). At univariable analysis, significant predictive factors were age (OR 0.97 [Cl 95% 0.95-0.99], P = 0.02), radiological size (OR 0.97 [CI 95% 0.96-0.99], P < 0.001), multifocality (OR 0.53 [CI 95% 0.271.05], P = 0.06), breast inflammation (OR 0.15 [CI 95% 0.07-0.32], P < 0.001) and the type of hormone receptors (P = 0.12). In multivariable analysis, all these factors but age were significant factors and thus considered as independent predictive factors. Conclusion. - This work permitted to identify independent predictive factors of breast conservative surgery after NAC for breast cancer that will be included in a risk scoring system that we aim to evaluate prospectively. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 27 条
[1]   Predictors of Surgery Types after Neoadjuvant Therapy for Advanced Stage Breast Cancer: Analysis from Florida Population-Based Cancer Registry (1996-2009) [J].
Al-Azhri, Jamila ;
Koru-Sengul, Tulay ;
Miao, Feng ;
Saclarides, Constantine ;
Byrne, Margaret M. ;
Avisar, Eli .
BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2015, 9 :99-108
[2]  
[Anonymous], 2013, FRANCIM
[3]   Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies - correlation with subsequent surgical excisions [J].
Badoual, C ;
Maruani, A ;
Ghorra, C ;
Lebas, P ;
Avigdor, S ;
Michenet, P .
BREAST, 2005, 14 (01) :22-27
[4]   The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore [J].
Caudle, Abigail S. ;
Hunt, Kelly K. .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2011, 23 (01) :31-36
[5]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172
[6]   Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008 [J].
Cossetti, Rachel J. D. ;
Tyldesley, Scott K. ;
Speers, Caroline H. ;
Zheng, Yvonne ;
Gelmon, Karen A. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) :65-U106
[7]   International Variation in Female Breast Cancer Incidence and Mortality Rates [J].
DeSantis, Carol E. ;
Bray, Freddie ;
Ferlay, Jacques ;
Lortet-Tieulent, Joannie ;
Anderson, Benjamin O. ;
Jemal, Ahmedin .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (10) :1495-1506
[8]   Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908 [J].
Frasci, G. ;
D'Aiuto, G. ;
Comella, P. ;
D'Aiuto, M. ;
Di Bonito, M. ;
Ruffolo, P. ;
Iodice, G. ;
Petrillo, A. ;
Lastoria, S. ;
Oliviero, P. ;
Capasso, I. ;
Montella, M. ;
Siani, C. ;
Santangelo, M. ;
Vizioli, L. ;
Comella, G. .
ANNALS OF ONCOLOGY, 2010, 21 (04) :707-716
[9]   Clinicopathological and genomics predictors of response to neoadjuvant chemotherapy in breast cancer [J].
Frati, A. ;
Lesieur, B. ;
Benbara, A. ;
Bezu, C. ;
Uzan, S. ;
Rouzier, R. ;
Coutant, C. .
GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2010, 38 (7-8) :475-480
[10]   Neoadjuvant chemotherapy in HER2-positive and triple-negative breast cancer [J].
Goncalves, Anthony .
BULLETIN DU CANCER, 2016, 103 (06) :S76-S89